Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review
Wajid Siddiqui1, Yasir Ahmed2, Helmut Albrecht3
1Department of Infectious Diseases, Phoebe Putney Memorial Hospital, Albany, Georgia, USA.
Abstract:
Pseudozyma spp are amorphic yeasts. They are commonly plant pathogens, but rarely cause invasive fungal disease in humans. Only three cases of central venous catheter (CVC)-associated blood stream infections due to this organism have been reported in the literature. Main underlying risk factors for Pseudozyma spp infection are bowel surgery, CVC and total parenteral nutrition. We present a rare case of Pseudozyma spp catheter-associated blood stream infection that was successfully treated with antifungal therapy and removal of CVC. It is important to recognise and differentiate this species from other yeasts as it may require the use of amphotericin B or voriconazole instead of fluconazole, to which the organism is variably resistant.
Insights
Pseudozyma yeasts rarely cause human infections, but can lead to central venous catheter infections. Early recognition and specific antifungal treatment are crucial for successful outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
Background:
- Pseudozyma yeasts are typically plant pathogens with rare human infections.
- Central venous catheter (CVC)-associated bloodstream infections (BSIs) are uncommon.
- Reported risk factors include bowel surgery, CVCs, and total parenteral nutrition.
Observation:
- A rare case of Pseudozyma spp catheter-associated bloodstream infection is presented.
- The patient had a central venous catheter (CVC).
Findings:
- Successful treatment involved antifungal therapy and CVC removal.
- Pseudozyma spp exhibit variable resistance to fluconazole.
- Amphotericin B or voriconazole may be necessary for treatment.
Implications:
- Highlights the importance of identifying Pseudozyma spp in clinical settings.
- Guides appropriate antifungal selection for Pseudozyma BSIs.
- Emphasizes the need for vigilance in immunocompromised patients with CVCs.
More Related Videos
Related Concept Videos
Fungal Group Zygomycota
Clinical Significance of Antibiotic Resistance
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Automated Microbial Diagnostics
Bacterial Phylum Spirochaetes
Atypical Pneumonia

